Abstract:IntroductionDepression, sleep disturbances, and cognitive deficits often co-occur. Compared to non-medicated controls, people using antidepressant medications (particularly serotonin agonists) often have improved sleep including increased slow wave sleep, quality and continuity. Improvements to cognition after antidepressant treatments are also common including benefits to reaction time, inhibition, and memory. Importantly, circadian deficits, including sleep onset latency, fragmentation, and phase shifts are common in patients with depression, yet the effect of antidepressant medication on circadian indicators is unclear. The current project examined sleep, circadian entrainment, and cognition in college students who were diagnosed with depression and using serotonin agonists and in those without depressive symptoms.MethodsParticipants completed cognitive tasks that assessed reaction time, memory, attention, inhibition, and logical reasoning via the Automated Neuropsychological Assessment Metric between 1100-1700 two times, first at study enrollment and second after a two-week study interval. After initial cognitive assessments, participants wore actigraphs for two weeks from which we extracted their sleep-wake patterns, total sleep time(TST), time in bed(TIB), sleep-onset latency(SOL), sleep efficiency, and wake after sleep onset(WASO). Study 1 included 15 undergraduate students (11F, 7 antidepressant users, Mage=19.53) and Study 2 included 25 graduate students (21F, 13 antidepressant users, Mage=25.37), all recruited from James Madison University.ResultsStudy 1 found that undergraduate antidepressant users had longer TIB, TST, and SOL. No cognitive or entrainment differences were found between drug use conditions. Within the antidepressant group, higher dosage predicted shorter TIB(r2=.64, p<.05), poorer spatial processing speed(r2=.73, p<.05) and logical relation performance(r2=.81, p<.05). In study 2, no circadian or cognitive differences were present across drug conditions. Deficits in WASO and sleep efficiency for antidepressant users were present. Within the antidepressant group, years of antidepressant use and dosage predicted poorer reaction time(r2=.84, p<.05), inhibition(r2=.70, p<.05), and spatial processing(r2=.98, p<.05). Self-reported wake episodes also predicted poorer reaction time and inhibition. Years of antidepressant use, dosage, and time of antidepressant use predicted TIB(r2=.73, p<.05), and time of antidepressant use predicted TST(sr2=.79, p<.05).ConclusionFuture studies should use longitudinal research designs and prospective methods to examine the impact of antidepressant medications on circadian rhythms, sleep and cognition.Support (If Any)

Increased Odds of Cognitive Impairment in Adults with Depressive Symptoms and Antidepressant Use

Depression Affects Intrinsic Brain Activity in Patients with Mild Cognitive Impairment.

Antidepressant use and cognitive decline in community-dwelling elderly people - The Three-City Cohort

Psychiatric symptoms, associated pharmacological treatments and cognitive function: A population-based study of men

Antidepressant use in relation to dementia risk, cognitive decline, and brain atrophy

Association of antidepressant and benzodiazepine use, and anticholinergic burden with cognitive performance in schizophrenia

Cognitive Performance Deficits Are Associated with Clinically Significant Depression Symptoms in Older US Adults

Features of cognitive impairment and related risk factors in patients with major depressive disorder: A case-control study

Factors Associated with Objective and Subjective Cognitive Impairment in Chinese Patients with Acute Major Depressive Disorder

Association of depression and cognitive performance in US older adults: a secondary analysis of cross-sectional data using NHANES 2013-2014

Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer Disease

Clinical symptoms and their relationship with cognitive impairment in elderly patients with depressive disorder

Association between depression, antidepressant use, and the incidence of atherosclerotic cardiovascular diseases

Associations of antidepressant medication consumption with changes in personality pathology and quality of life among community-dwelling adults

Associations of Clinically Relevant Levels of Depressive Symptoms and Antidepressant Use with Mortality in African American Health

The Effect of Short-Term Use of Benzodiazepines on Cognitive Function of Major Depressive Disorder Patients Being Treated with Antidepressants.

0213 Circadian Entrainment and Cognition in College Students using Antidepressants

Association between Depressive Mood, Antidepressant Therapy and Neuropsychological Performances: Results from a Cross-Sectional Study on Elderly Patients

Altered Hippocampal Network Activity Links Memory Deficits and Depressive Symptoms in Amnestic Mild Cognitive Impairment

Antidepressant exposure and long‐term dementia risk in a nationwide retrospective study on US veterans with midlife major depressive disorder

Brain-Cognition Associations in Older Patients With Remitted Major Depressive Disorder or Mild Cognitive Impairment: A Multivariate Analysis of Gray and White Matter Integrity